| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.47B | 84.19B | 81.76B | 94.44B | 81.75B | 66.81B |
| Gross Profit | 13.51B | 13.15B | 13.10B | 16.55B | 15.44B | 11.77B |
| EBITDA | 11.23B | 10.81B | 10.81B | 12.73B | 11.69B | 8.54B |
| Net Income | 3.54B | 3.33B | 3.68B | 5.36B | 5.05B | 2.98B |
Balance Sheet | ||||||
| Total Assets | 68.75B | 69.88B | 66.83B | 68.28B | 63.59B | 55.31B |
| Cash, Cash Equivalents and Short-Term Investments | 4.42B | 2.19B | 4.26B | 3.19B | 4.71B | 5.80B |
| Total Debt | 26.28B | 22.44B | 20.83B | 20.22B | 19.02B | 18.35B |
| Total Liabilities | 46.91B | 45.66B | 43.94B | 44.58B | 44.09B | 41.23B |
| Stockholders Equity | 21.54B | 23.79B | 22.48B | 23.24B | 19.04B | 13.78B |
Cash Flow | ||||||
| Free Cash Flow | 6.55B | 5.79B | 5.88B | 7.05B | 6.26B | 4.78B |
| Operating Cash Flow | 9.39B | 8.72B | 9.26B | 10.96B | 9.99B | 7.70B |
| Investing Cash Flow | -3.11B | -2.39B | -2.18B | -3.18B | -4.82B | -3.64B |
| Financing Cash Flow | -5.25B | -6.35B | -6.90B | -7.41B | -6.22B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €10.16B | 6.17 | 15.13% | 3.54% | 5.95% | 82.99% | |
76 Outperform | €51.77B | 15.20 | 16.16% | 3.94% | 0.77% | 12.83% | |
73 Outperform | €6.42B | 13.71 | 9.56% | ― | 0.11% | 2.58% | |
71 Outperform | €21.79B | 14.13 | 8.49% | 6.61% | 8.66% | 5.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | €2.09B | 47.25 | 5.78% | 0.47% | 13.44% | 113.13% |